Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NAGLAZYME vs NALMEFENE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NAGLAZYME vs NALMEFENE: Safety Overview

Metric NAGLAZYME NALMEFENE
Total FAERS Reports 414 197
Deaths Reported 18 77
Death Rate 4.3% 39.1%
Hospitalizations 88 118
Average Patient Age 12.2 yrs 44.2 yrs
% Female Patients N/A 39.3%
FDA Approval Date N/A Apr 17, 1995
Manufacturer N/A Purdue Pharma L.P.
Route N/A INTRAMUSCULAR
Marketing Status N/A Discontinued